Session Abstract – PMWC 2022 Silicon Valley


The PMWC 2022 Microbial Profiling Showcase will provide a 15-minute time slot for selected companies in the Microbiome and Pathogen ID fields. The human microbiome is composed of a wide variety of microorganisms that are essential for maintaining human health and preventing disease. Research in this area is accelerating due to the rapid development in genome sequencing technologies. This showcase will present some of the leading companies in microbial profiling and pathogen identification.


Confirmed Presenting Companies:

 Session Chair Profile

Ph.D., MSC, DSC, Distinguished University Professor, University of Maryland College Park and Johns Hopkins Bloomberg School of Public Health, President, CosmosID, Inc.

Biography
Rita R. Colwell is a Distinguished University Professor at the University of Maryland and at the Johns Hopkins University Bloomberg School of Public Health. Colwell’s research interests are focused on global infectious diseases, water and health. She is currently developing an international network to address emerging infectious diseases and water issues, including safe drinking water for both the developed and developing world. Colwell served as the 11th director of the National Science Foundation from 1998 to 2004. Her major interests include K–12 sciences and mathematics education, graduate science and engineering education, and the increased participation of women and minorities in science and engineering. She has held many advisory positions in the U.S. government, nonprofit science policy organizations and private foundations, as well as in the international scientific research community. She is a member of the National Academy of Sciences, the Royal Swedish Academy of Sciences, Stockholm, the Royal Society of Canada, the American Academy of Arts and Sciences, and the American Philosophical Society.


 Speaker Profile

Ph.D., VP, Research & Development, Metabolon

Biography
Dr. Foster leads the software engineering, data science, IT operations, and biostatistics teams and guides data strategy. His teams build AI applications that enable and enhance Metabolon’s industry-leading capabilities. He holds a Bachelor of Science in Physics from Duke University and a Ph.D. in Physics from the University of Calgary.


Microbial Profiling Showcase:
Metabolon

Metabolon, the global leader in metabolomics, has a mission to deliver metabolomics data and insights that expand and accelerate the impact of life sciences research. Our industry-leading data helps to address challenging and pressing questions - accelerating research and development success.

 Speaker Profile

Ph.D., CEO, EzBiome

Biography
Dr. Nur A Hasan is a molecular microbiologist with experiences in microbial genomics, microbiome, bioinformatics and molecular ecology. Dr. Hasan is the Chief Executive Officer of EzBiome Inc., USA. He received his Bachelor and Master’s in microbiology, M.B.A in Marketing and Ph.D. in Microbiology and Genomics. In his multidisciplinary research experience, Dr. Hasan contributed on various independent research projects in the field of infectious communicable diseases and led numerous large-scale genomic, metagenomic and microbiome projects that resulted in multiple patents, 80+ peer-reviewed articles, and over 100 abstracts and conference proceedings on microbiome, biomarker discovery, molecular ecology, and infectious diseases. Dr. Hasan taught numerous webinars and workshops on microbiome and bioinformatics and frequently present his research in scientific conferences nationally and internationally. He is an editorial board member of several scientific journals and continue to serve as ad doc reviewer for 18+ scientific journals.


Microbial Profiling Showcase:
EzBiome

EzBiome is a microbiome company which applies precision microbiome discovery platform to shorten the time for discovery and development of microbiota-based therapeutics and companion diagnostics for microbiome-related diseases.

EzBioCloud – An Advanced Microbiome Platform for Discovery of Exciting New Biology and Transformative Therapeutics!
The microbiome plays a critical role in human health and disease and Bioinformatics is the key to uncover cross-disciplinary microbiome data for novel biomarker discovery, product development, disease dynamics, effects of drugs on the microbiome and vice-versa. The presentation will showcase EzBioCloud Precision Microbiome Discovery Platform and demonstrates how it helps shorten the time for discovery and development of therapeutics and companion diagnostics for microbiome-related diseases.

 Speaker Profile

Ph.D., Director of Data Science and Bioinformatics, Diversigen

Biography
Tonya Ward is an accomplished microbiome scientist with expertise in clinical and experimental research, bioinformatics, next generation sequencing and translating data into insights. She's passionate about accelerating microbiome science through reproducible research and enabling high-power studies by creating services that scale. Tonya holds a Bachelor of Science in Genetics from the University of Western Ontario and a Ph.D. in Biochemistry from the University of Ottawa.


Microbial Profiling Showcase:
Diversigen

Diversigen empowers microbiome discovery through sequencing, analysis, and consulting services. The combined bench strength of Diversigen is unparalleled in the industry, providing you with access to those who are pioneering advancements in the microbiome field.

Metatranscriptomics: Enabling Biomarker Discovery

 Speaker Profile

QIAGEN

Biography
Speaker QIAGEN


Microbial Profiling Showcase:
QIAGEN

A leader in clinical molecular testing, QIAGEN delivers Sample to Insight solutions to more than 500,000 global customers. In our commitment to advancing precision medicine, we provide bioinformatics software solutions that standardize interpretation and reporting for better patient care.

 Speaker Profile

Ph.D., VP, Research & Development, R&D, DNA Genotek Inc

Biography
Dr. Iwasiow completed a post-doctoral fellowship at the National Research Council of Canada and he holds a Ph.D. degree in Cellular and Molecular Medicine from the University of Ottawa. Dr. Iwasiow he has held various positions across Research and Product Development at DNA Genotek where he and his team contribute significantly to the company's patent portfolio in numerous areas including nucleic acid stabilization methods and physical sample collection devices. Dr. Iwasiow advanced his career within the organization, resulting in the appointment to his current role of Vice President of Innovation and Technology. Under his leadership, the team contributed to successful 510(k) clearances of Oragene•Dx, the first non-invasive DNA collection device for at-home and direct to consumer use. Most recently his team’s efforts lead to a 510(k) clearance of OMNIgene•GUT Dx, the first of its kind device for self-collection and stabilization of fecal samples for microbiome profiling.


Microbial Profiling Showcase:
DNA Genotek Inc

DNA Genotek Inc., Novosanis and Diversigen are subsidiaries of OraSure Technologies, Inc. working to provide high-quality sample collection products and comprehensive services for sample processing, sequencing, and bioinformatic analysis. Our solutions enable microbiome discovery for academic, pharmaceutical, biotechnology, agricultural and environmental applications.

A New Benchmark for Gut Microbiome Collections
DNA Genotek introduces OMNIgene®•GUT Dx, the first FDA-cleared device for the collection of human fecal samples and assessment of the microbiome profile. Validated using WGS, it provides a stable and reproducible representation of the in-vivo fecal bacterial community composition.